Amelogenins modulate cytokine expression in LPS-challenged cultured human macrophages

Cytokine

Volumn 58, Issue 2, 2012, Pages 274-279

  Almqvist, Sofia ^a,b,c   Werthén, Maria ^b,c   Lyngstadaas, S Petter ^d   Gretzer, Christina ^a,e   Thomsen, Peter ^a,b,f  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Institute of Biomaterials and Cell Therapy   (Sweden)

^c Mölnlycke Research AB   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

^e Astra Tech AB   (Sweden)

^f BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy   (Sweden)

Author keywords

Amelogenins; Cytokine; Extracellular matrix (ECM); Inflammation; Macrophage

Indexed keywords

AMELOGENIN; BETA CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE; PROTEIN AMAC 1; PROTEIN CCL18; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR;

AMELOGENIN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES;

EID: 84859213466     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.02.001     Document Type: Article

References (50)

1. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009, 175:2454-2462.
2. Martin P., D'Souza D., Martin J., Grose R., Cooper L., Maki R., et al. Wound healing in the PU.1 null mouse - tissue repair is not dependent on inflammatory cells. Curr Biol 2003, 13:1122-1128.
3. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005, 15:599-607.
4. Duffield J.S. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 2003, 104:27-38.
5. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212.
6. Bosshardt D.D. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol 2008, 35:87-105.
7. Heijl L., Heden G., Svärdström G., östgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997, 24:705-714.
8. Gestrelius S., Lyngstadaas S.P., Hammarström L. Emdogain - periodontal regeneration based on biomimicry. Clin Oral Investig 2000, 4:120-125.
9. Lyngstadaas S.P., Wohlfahrt J.C., Brookes S.J., Paine M.L., Snead M.L., Reseland J.E. Enamel matrix proteins; old molecules for new applications. Orthod Craniofac Res 2009, 12:243-253.
10. Romanelli M., Dini V., Vowden P., Ågren M.S. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence. Clin Interv Aging 2008, 3:263-272.
11. Vowden P., Romanelli M., Peter R., Boström A., Josefsson A., Stege H. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers. Wound Repair Regen 2006, 14:240-246.
12. Vowden P., Romanelli M., Price P. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers. J Wound Care 2007, 16:189-195.
13. Hammarström L., Heijl L., Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997, 24:669-677.
14. Heden G., Wennström J., Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999, 26:855-860.
15. Lyngstadaas S.P., Lundberg E., Ekdahl H., Andersson C., Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001, 28:181-188.
16. Wennström J.L., Lindhe J. Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 2002, 29:9-14.
17. Almqvist S., Werthén M., Johansson A., Törnqvist J., Ågren M.S., Thomsen P. Evaluation of a near-senescent human dermal fibroblast cell line and effect of amelogenin. Br J Dermatol 2009, 160:1163-1171.
18. Almqvist S., Werthén M., Johansson A., Ågren M.S., Thomsen P., Lyngstadaas S.P. Amelogenin is phagocytized and induces changes in integrin configuration, gene expression and proliferation of cultured normal human dermal fibroblasts. J Mater Sci Mater Med 2010, 21:947-954.
19. Mirastschijski U., Konrad D., Lundberg E., Lyngstadaas S.P., Jorgensen L.N., Ågren M.S. Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 2004, 12:100-108.
20. Yuan K., Chen C.L., Lin M.T. Enamel matrix derivative exhibits angiogenic effect in vitro and in a murine model. J Clin Periodontol 2003, 30:732-738.
21. Fincham A.G., Moradian-Oldak J., Simmer J.P. The structural biology of the developing dental enamel matrix. J Struct Biol 1999, 126:270-299.
22. Halthur T.J., Björklund A., Elofsson U.M. Self-assembly/aggregation behavior and adsorption of enamel matrix derivate protein to silica surfaces. Langmuir 2006, 22:2227-2234.
23. Brookes S.J., Bonass W.A., Kirkham J., Robinson C. The human amelogenin C-terminal sequence is completely homologous to the C-terminal sequence of amelogenin in all species so far studied. J Dent Res 1994, 73:716-717.
24. Snead M.L., Bringas P., Bessem C., Slavkin H.C. De novo gene expression detected by amelogenin gene transcript analysis. Dev Biol 1984, 104:255-258.
25. Myhre A.E., Lyngstadaas S.P., Dahle M.K., Stuestol J.F., Foster S.J., Thiemermann C., et al. Anti-inflammatory properties of enamel matrix derivative in human blood. J Periodontal Res 2006, 41:208-213.
26. Gundersen R.Y., Ruud T.E., Jorgensen P.F., Scholz T., Reinholt F.P., Wang J.E., et al. Systemic administration of enamel matrix derivative to lipopolysaccharide-challenged pigs: effects on the inflammatory response. Surg Infect (Larchmt) 2008, 9:161-169.
27. Sato S., Kitagawa M., Sakamoto K., Iizuka S., Kudo Y., Ogawa I., et al. Enamel matrix derivative exhibits anti-inflammatory properties in monocytes. J Periodontol 2008, 79:535-540.
28. Hoang A.M., Klebe R.J., Steffensen B., Ryu O.H., Simmer J.P., Cochran D.L. Amelogenin is a cell adhesion protein. J Dent Res 2002, 81:497-500.
29. Maycock J., Wood S.R., Brookes S.J., Shore R.C., Robinson C., Kirkham J. Characterization of a porcine amelogenin preparation, EMDOGAIN, a biological treatment for periodontal disease. Connect Tissue Res 2002, 43:472-476.
30. Pertoft H., Johnsson A., Wärmegård B., Seljelid R. Separation of human monocytes on density gradients of Percoll. J Immunol Methods 1980, 33:221-229.
31. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004, 9:283-289.
32. Singer A.J., Clark R.A. Cutaneous wound healing. N Engl J Med 1999, 341:738-746.
33. Ågren M.S., Eaglstein W.H., Ferguson M.W., Harding K.G., Moore K., Saarialho-Kere U.K., et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) 2000, 210:3-17.
34. Gratchev A., Kzhyshkowska J., Kothe K., Muller-Molinet I., Kannookadan S., Utikal J., et al. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006, 211:473-486.
35. Gratchev A., Schledzewski K., Guillot P., Goerdt S. Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol Appl Skin Physiol 2001, 14:272-279.
36. Kodelja V., Muller C., Politz O., Hakij N., Orfanos C.E., Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998, 160:1411-1418.
37. Rumalla V.K., Borah G.L. Cytokines, growth factors, and plastic surgery. Plast Reconstr Surg 2001, 108:719-733.
38. Efron P.A., Moldawer L.L. Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair response. J Burn Care Rehabil 2004, 25:149-160.
39. Gallucci R.M., Simeonova P.P., Matheson J.M., Kommineni C., Guriel J.L., Sugawara T., et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000, 14:2525-2531.
40. Caruso C., Candore G., Cigna D., Colucci A.T., Modica M.A. Biological significance of soluble IL-2 receptor. Mediators Inflamm 1993, 2:3-21.
41. Lotze M.T., Custer M.C., Sharrow S.O., Rubin L.A., Nelson D.L., Rosenberg S.A. In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration. Cancer Res 1987, 47:2188-2195.
42. DiPietro L.A., Burdick M., Low Q.E., Kunkel S.L., Strieter R.M. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998, 101:1693-1698.
43. Ferreira A.M., Rollins B.J., Faunce D.E., Burns A.L., Zhu X., Dipietro L.A. The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine 2005, 30:64-71.
44. Engelhardt E., Toksoy A., Goebeler M., Debus S., Brocker E.B., Gillitzer R. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998, 153:1849-1860.
45. Viswanathan H.L., Berry J.E., Foster B.L., Gibson C.W., Li Y., Kulkarni A.B., et al. Amelogenin: a potential regulator of cementum-associated genes. J Periodontol 2003, 74:1423-1431.
46. Almqvist S., Werthén M., Lyngstadaas S.P., Ågren M.S., Thomsen P. Amelogenins promote an alternatively activated macrophage phenotype in vitro. Int J Nano Biomater 2011, 3:282-298.
47. Almqvist S., Kleinman H.K., Werthen M., Thomsen P., Ågren M.S. Effects of amelogenins on angiogenesis-associated processes of endothelial cells. J Wound Care 2011, 20(68):70-75.
48. Narani N., Owen G.R., Hakkinen L., Putnins E., Larjava H. Enamel matrix proteins bind to wound matrix proteins and regulate their cell-adhesive properties. Eur J Oral Sci 2007, 115:288-295.
49. Suzuki N., Ohyama M., Maeno M., Ito K., Otsuka K. Attachment of human periodontal ligament cells to enamel matrix-derived protein is mediated via interaction between BSP-like molecules and integrin alpha(v)beta3. J Periodontol 2001, 72:1520-1526.
50. van der Pauw M.T., Everts V., Beertsen W. Expression of integrins by human periodontal ligament and gingival fibroblasts and their involvement in fibroblast adhesion to enamel matrix-derived proteins. J Periodontal Res 2002, 37:317-323.